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Abstract
Background: New mechanisms that regulate neural stem cell (NSC) expansion will contribute to improved assay systems
and the emerging regenerative approach that targets endogenous stem cells. Expanding knowledge on the control of stem
cell self renewal will also lead to new approaches for targeting the stem cell population of cancers.
Methodology/Principal Findings: Here we show that Cholera toxin regulates two recently characterized NSC markers, the
Tie2 receptor and the transcription factor Hes3, and promotes the expansion of NSCs in culture. Cholera toxin increases
immunoreactivity for the Tie2 receptor and rapidly induces the nuclear localization of Hes3. This is followed by powerful
cultured NSC expansion and induction of proliferation both in the presence and absence of mitogen.
Conclusions/Significance: Ourdatasuggestanewcellbiologicalmechanismthatregulatestheselfrenewalanddifferentiation
properties of stem cells, providing a new logic to manipulate NSCs in the context of regenerative disease and cancer.
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Introduction
The adult mammalian brain retains the ability to generate new
neurons in small and physically confined areas, the sub-ventricular
zone (SVZ) and the dentate gyrus (DG) of the hippocampus
[1,2,3,4,5,6,7,8]. In addition to a role in cell replacement,
endogenous NSC and neural precursor populations expand in
response to injury [9,10,11,12,13,14] and pharmacological
manipulations [15,16,17,18,19,20,21,22], suggesting a role in
sensing the state of the tissue and possibly in its repair.
A role for endogenous NSCs in repair is supported by our
previous observations that their expansion by various pharmaco-
logical activations is followed by rescue of injured neurons in animal
models of stroke and Parkinson’s disease [22,23,24,25]. These
pharmacological treatments include the Notch receptor ligand Dll4,
the Tie2 receptor ligand Ang2, insulin, and an inhibitor of JAK
kinase. These factors were selected because they converge onto a
signal transduction pathway that is critical for the survival of NSCs
and involves phosphorylation of STAT3 on the serine residue and
induction of the transcription factor Hes3. Using Hes3 and Tie2 as
novel markers of NSCs, we have shown that such cells are present
throughout the adult central nervous system and their numbers can
be powerfully expanded by pharmacological treatments, with
subsequent neuroprotection and behavioral recovery. Given the
relatively fast onset of protection, the lack of evidence for newly
generated neurons, theexpression byNSCsofcytokinesthat protect
neurons (e.g. sonic hedgehog), and the close physical association
between the NSCs and neurons, it is possible that the expansion of
the endogenous NSC population results in increased neuroprotec-
tion by trophic support.
Here we expand the arsenal of pharmacological manipulations
that regulate NSC numbers by studying the regulation of the pro-
survival pathway by cholera toxin. Cholera toxin is comprised of 5
copies of the B subunit that bind to GM1+ gangliosides on lipid
rafts, and a single copy of the A subunit that enters the cell via
endocytosis, subsequently increasing cAMP levels. In addition,
cholera toxin regulates several proteins of the Endoplasmic
Reticulum (ER) stress response and the ER associated degradation
(ERAD) pathway [26]. This suggests that cholera toxin can mimic
stresses known to activate regenerative responses and may increase
the expansion of cultured NSCs. We investigated whether the
toxin can modulate the signal transduction pathway that is critical
for NSC survival [22,23,25] and whether it can promote the
expansion of cultured NSCs. Our findings show that cholera toxin
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induces powerful expansion of cultured NSCs.
Results
Fluorescence-conjugated Cholera toxin B subunit (CholB)
recognizes GM1+ gangliosides on lipid rafts and can be used to
label cells differentiating towards the neuronal lineage [27,28,29].
In established mouse fetal NSC cultures, CholB exhibits no
binding or very limited binding to stem cells, but strong labeling of
rare contaminating DCX+ neuroblasts and fibroblasts (Figure 1a
and Figure S1a,b). GM1+ lipid rafts have been implicated in
cytoskeletal re-organization [30]; here we show high concentration
of the CholB label on DCX+ cell processes that are selectively
down-regulating the stem cell marker nestin (magnification in
Figure 1a). Pulse-chase experiments with CholB labeled with
different fluorophores showed that throughout a period of 16 h,
fetal mouse NSCs show very little labeling, whereas DCX+ cells
are continuously receptive to the three fluorophor-CholB used
(Alexa488 at t=0, Alexa594 at t=8 h, and Cy5 after fixation at
t=16 h) (Figure 1b). In the adult monkey striatum, Hes3+ neural
precursors also show very low CholB labeling relative to
differentiated cells (Figure 1c and Figure S1c,d). These results
show that rodent and primate NSCs and precursors have a small
number of lipid rafts relative to differentiated cells.
A recent paper cautions that immunocytochemical measure-
ment of ganglioside expression may overestimate their expression
(which can be independently determined by biochemical means)
[31]. Here we have scored ganglioside expressing cells using a
fluorescence conjugated cholera B subunit product (Invitrogen)
and high-power confocal microscopy. Cells exhibiting labeling
with the characteristic shape of lipid rafts were considered positive,
thus avoiding false positives from background signal. We do note,
however, that the signal-to-noise ratio was very high as can be seen
in Figure 2a and Figure S2. Consistent with this previous study, we
find that cultured NSCs exhibit low levels of Cholera toxin B
subunit binding, but we also do caution here of the need to
perform ganglioside expression studies carefully.
We have recently shown that fetal and adult rodent and primate
NSCs in culture as well as a newly identified multipotent neural
precursor in the adult brain express the angiopoietin receptor Tie2
and the transcription factor Hes3 [22,25,32,33]. Tie2 and Hes3
immunoreactivity are lost following induction of differentiation. In
fetal mouse NSC cultures, an antibody against the C-terminus of
Tie2 suggests that the receptor is concentrated in recycling early
endosomes (Figure 2a,b), a process regulated by lipid rafts [30].
This observation suggested that treatment with the active form of
Cholera toxin (CholAB) may regulate the incidence of Tie2+
endosomes. A 2 day treatment of adult rat SVZ NSCs with
CholAB increased the occurrence of Tie2+ structures relative to
controls (Figure 2c). Significance p values are given in Table S1.
Downstream of Tie2 signaling is a pathway that induces Hes3
expression and regulates NSC survival [23]. In culture conditions
that support the self-renewal of mouse fetal NSCs in vitro (in the
presence of FGF2), Hes3 is localized both in the nucleus and the
cytoplasm of fetal NSCs (Figure 3a,b; Figure S2; Figure S3),
whereas when differentiation is induced (by a 2-day FGF2
withdrawal), Hes3 is only found in the cytoplasm. (Eventually,
after approximately a total of 7 days of differentiation, all Hes3
signal is lost [25]). This suggests that nuclear Hes3 identifies the
self-renewing, dividing NSC. When fetal NSCs were treated with
CholAB for 2 days (following 4 days in FGF2), the nuclear
localization of Hes3 markedly increased. This was true both in the
presence and the absence of FGF2, suggesting that CholAB may
promote the self-renewal state of these cultures and possibly
maintain them in the division cycle even after mitogen (FGF2)
withdrawal. We note that at earlier times within each passage (i.e.
when the cultured cells are proliferating fast) a greater percentage
of nuclear Hes3 is observed than at later times as used here (i.e.
when the cultures are reaching confluence and the proliferation
rates decrease) (data not shown).
When mouse fetal NSC cultures were treated with CholAB in
the presence of FGF2 (for 4 days), a small but significant increase
in total cell number and a large increase in DCX+ cell number
was measured (Figure 4a,c). A much greater effect (relative to
controls) was obtained when CholAB was added immediately after
Figure 1. Fetal NSCs exhibit low Cholera toxin B subunit
binding. (a) Differentiating DCX+ cells but not fetal NSCs are labeled
by CholB in vitro [Magnified images show accumulation of CholB in a
DCX+ cell process that is downregulating nestin expression. (b) Multiple
pulse-chases by CholB label differentiating cells and not fetal NSCs in
vitro. (c) Hes3+ neural precursors in the adult monkey striatum are not
labeled by CholB. [Size bars: 20 mm].
doi:10.1371/journal.pone.0010841.g001
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conditions exit the cell cycle [34,35] whereas CholAB – treated
cultures increased in cell density (Figure 4b,c). Adherent fetal NSC
cultures are highly homogenous, but they also contain small
percentages (.1%) of DCX+ neuronal precursors. In the presence
of FGF2, CholAB did not induce the acquisition of differentiation
markers, but it expanded the DCX+ populations (Figure 4d,e;
Figure S4a,b). This is concluded by the increase in DCX+ colony
size but not number (data not shown). These results suggest that
CholAB – treated cells in the absence of mitogen are still dividing.
To address this possibility, fetal NSC cultures were plated in FGF2
for initial expansion, after which FGF2 was removed for 8 days,
and during the last two days the thymidine analog EdU was added
to the medium to detect any proliferating cells. Under those
conditions, no cells in the control groups incorporated EdU,
whereas 25%65 of total cells and 15%63 of DCX+ cells in the
CholAB – treated groups still divided (Figure 5a,b). These data
show that CholAB promotes the proliferation of cells in a minimal
culture medium (without serum) in the absence of a mitogen.
When the CholAB – treated cultures were forced to differentiate
(by removal of FGF2, CholAB, and the addition of B27 cell culture
supplement and neurotrophins for 7 days), neurons, astrocytes,
and oligodendrocytes were generated (Figure 5c), showing that the
potential of the culture en masse to generate all three major
lineages of neural tissue was not lost.
We have previously reported a pharmacological treatment that
promotes the survival and expansion of fetal and adult NSCs in
culture and of adult neural precursors in vivo [25]. This combined
treatment (CT) contains the Tie2 ligand Ang2, the Notch ligand Dll4,
a JAK kinase inhibitor, and insulin. In these experiments, insulin is
contained in the culture medium throughout their duration. We
investigated whether the pro-expansion capabilities of CT and
CholAB can be combined to establish a new treatment that will
maximizeNSCnumberincrease.WefoundthatCTandCholABco-
operate to increase mouse fetal NS Cn u m b e r si nc u l t u r e sg r o w nf o r5
days in the presence of FGF2 (Figure 6). These results show that a
combination of pharmacological treatments that affect signal
transduction and cell biological processes can greatly enhance the
efficiency of primary cell culture.
Cultures of NSCs from the adult rat SVZ express similar
markers to their fetal counterparts including Hes3, Tie2 and Sox2
[23,25]. Here, we show that the expression of these markers is
retained in adult cultures 5 days after FGF2 withdrawal, when
CholAB is added at the time of FGF2 withdrawal (Figure 7a–c).
CholAB treatment also increased Tie2 immuno-reactivity and
occurrence of the early endosomal structures that are strongly
labeled for C-terminus Tie2 (Figure 7a–c; Figure 2e) and the
number of adult NSCs in culture conditions that included FGF2
for 5 days (Figure 7d).
Figure 2. Cholera toxin regulates Tie2 receptors on NSCs. (a, b)
High power magnifications of Tie2+ intracellular structures in cultured
fetal NSCs. (c) CholAB (2-d treatment) increases the occurrence of Tie2+
structures in adult NSC cultures. [Size bars: 20 mm].
doi:10.1371/journal.pone.0010841.g002
Figure 3. Cholera toxin regulates Hes3 localization in NSCs. (a,
b) CholAB (2-d treatment) promotes the nuclear localization of Hes3 in
the presence (6 days in FGF2) and absence of FGF2 in fetal NSC cultures.
[Size bars: 20 mm].
doi:10.1371/journal.pone.0010841.g003
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Our results suggest that interference at the level of GM1+ lipid
raft function affects many properties of fetal and adult NSCs
including the regulation of receptors and transcription factors that
are shown to be critical for their survival and expansion, and may
provide new targets to manipulate NSCs in normal and cancerous
tissue.
Consistent with previous work from other labs [27,28,31], our
work suggests that NSCs exhibit little Cholera toxin B subunit
binding. In fact, at their most self-renewing, multipotent state,
soon after plating [35], they exhibit the lowest degree of binding,
with many NSCs showing no detectable binding at all. An
interpretation of these observations is that the effect of cholera
toxin is increasingly more potent to cells as they progress through
the process of differentiation. The end effect is a partial return to
their more immature state. This is supported by our mechanistic
data showing that treatment with the full (active) cholera toxin
protein increases immunostaining for the Tie2 receptor and
induces the nuclear localization of the transcription factor Hes3,
two processes characteristic of self renewing NSCs [22,23,24,25].
In the skin, a similar relation between lipid rafts recognized by
cholera toxin and cell maturity has been reported. Stem-like cells
in the skin show little cholera toxin binding, whereas more
differentiated, transit amplifying cells are enriched in lipid rafts
[36], strongly correlating to the neural cells reported here.
Intriguingly, human embryonic stem (hES) cells and human
induced pluripotent stem (hiPS) cells appear insensitive to cholera
toxin treatment [37], suggesting that the reprogramming of skin
fibroblasts to the pluripotent state involves the loss of signaling
through GM1 ganglioside – containing lipid rafts [and down-
stream Gs-coupled G protein –coupled receptor (GPCR) signal-
ing]. hES cells and hiPS cells, instead, are sensitive to pertussis
toxin, acting through Gi GPCR signaling [37]. These data suggest
that different stem cell states operate distinct cell surface receptors
leading to specific GPCR signaling pathways and that transitions
between stem cell states (forwards and backwards) switch between
these pathways.
Figure 5. Cholera toxin promotes NSC proliferation in vitro. (a, b) ChAB during an 8-day FGF2 withdrawal period maintains cell division
(assessed by incorporation of EdU added on days 7–8); low- and high power confocal projections are shown. (c) ChAB-treated fetal NSC cultures
generate neurons, astrocytes, and oligodendrocytes (ChAB was added during FGF2 treatment, 4-days and for another 2-days following FGF2
withdrawal; cells were then switched to B27 medium with added neurotrophins for 7-days). [Size bars: 100 mm].
doi:10.1371/journal.pone.0010841.g005
Figure 4. Cholera toxin promotes NSC expansion in vitro. (a) ChAB increases total cell and DCX+ cell number in a dose-dependent manner, in
fetal NSC cultures, in the presence of FGF2 (4-d treatment), as well as (b) following FGF2 withdrawal (6-d FGF2 followed by FGF2 withdrawal and
addition of ChAB, for 2-days). (c) Confocal projections of fetal NSC cultures described in (b). (d) Fetal NSC cultures expanded in FGF2 (4-days) and then
switched to FGF2+/- CholAB – containing medium exhibit expansion of DCX+ early neurons. (e) Fetal NSC cultures expanded in FGF2 (6-days) and
then switched to +/- CholAB conditions, in the absence of FGF2 (for 2-days) exhibit expansion of DCX+ early neurons. [Size bars: 100 mm].
doi:10.1371/journal.pone.0010841.g004
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nism that is critical to the survival and expansion of neural stem
cells in vitro and in vivo. This pathway involves cell surface
receptors (Notch, insulin, Tie2) and subsequent up-regulation of
the transcription factor Hes3 [22,23,24,25]. Here we show that a
cell biology mechanism that is activated by cholera toxin
converges into this pathway (at the levels of receptor trafficking
and Hes3 localization) to regulate stem cell and precursor cell
numbers. Our result showing that cholera toxin maintains cells in
a proliferative state in the absence of mitogen demonstrates the
importance of this signal transduction/cell biology interaction. It
also provides an experimental system to help elucidate the
mechanism controlling self renewal in neural stem cells. The
additive and powerful effects of receptor activation and cholera
toxin treatment suggest an untapped potential to interfere with
stem cell numbers in vivo.
Further work based on these discoveries is likely to generate
novel treatments that will allow the manipulation of endogenous
stem cells in the context of disease. We have previously shown that
treatments that increase NSC numbers in vivo also confer
neuroprotection and behavioral benefits in models of neurological
disease [22,23,25]. Recently, we have also shown that the presence
of Hes3 marks not only the normal endogenous NSC but also the
stem cell compartment in malignant brain tumors [24]. A key
finding is that the localization of Hes3 correlates strongly with the
proliferative state of stem cells: Quiescent endogenous stem cells
throughout the adult brain exclude Hes3 from the nucleus but
express it in the cytoplasm; when placed in culture under
mitogenic support that promotes proliferation, Hes3 is found in
both the cytoplasm and nucleus. Similarly, in human biopsies from
Grade IV Glioblastoma multiforme, Hes3 is found in both the
cytoplasm and nucleus. Uncovering novel treatments that will
affect Hes3 expression and localization will be a new set of tools in
regenerative and cancer medicine.
Figure 7. Cholera toxin promotes the expansion of adult NSCs in culture. (a–c) ChAB-treated adult NSCs in vitro co-express Hes3
and Sox2 following 5d FGF2 withdrawal. (d) ChAB promotes the expansion of adult NSC cultures in vitro (7-day treatment). [Size bars:
20 mm].
doi:10.1371/journal.pone.0010841.g007
Figure 6. Cholera toxin cooperates with pro-survival factors to
expand NSC numbers in vitro. CT and ChAB co-operate to increase
fetal NSC numbers (5-day treatment).
doi:10.1371/journal.pone.0010841.g006
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Ethics statement
Vertebrate Experiments (rodents). All research involving
animals was conducted in accordance with NINDS ACUC
(National Institute of Neurological Disorders and Stroke/Animal
Care and Use Committee) guidelines and after their approval
[Animal Protocol ASP#1204-05]. The animals were socially
housed and provided with environmental enrichment and novel
food items as provided for by the IACUC-approved NHP
enrichment program. Potential postoperative pain was treated
with ketoprofen IM, given preemptively at the time of surgery, and
for 2 days post-operatively. Prophylactic antibiotic treatment and
nursing care were also provided.
Non-Human Primate Experiments. The study was
conducted in accordance with the National Institutes of Health
Guidelines on the use of animals in research and was approved by
the Animal Care and Use Committee of the National Institutes of
Neurological Disorder and Stroke [Animal Protocol ASP#1294-
08; ‘‘Convection-enhanced delivery of stem cell inducing
compounds into the primate brain’’]. The animals were socially
housed and provided with environmental enrichment and novel
food items as provided for by the IACUC-approved NHP
enrichment program. Potential postoperative pain was treated
with ketoprofen IM, given preemptively at the time of surgery, and
for 2 days post-operatively. Prophylactic antibiotic treatment and
nursing care were also provided.
Cell Culture
E13.5 neural stem cells were grown as previously described
[34,38]. Cells were expanded in serum-free DMEM/F12 medium
with N2 supplement and FGF2 (20 ng/ml) for 5 days under 5%
oxygen conditions and were re-plated fresh or from frozen stocks
at 1,000–10,000 cells per cm
2. FGF2 was included throughout our
experiments, unless otherwise stated. Adult rat (3–6 months old) or
adult mouse (2–4 months old) SVZ Neural Stem Cell (NSC)
cultures were grown in the same medium as the fetal cultures.
In vivo Experiments – monkeys
Preparation of Gadolinium-DTPA. Clinical grade gadolinium-
DTPA (Berlex; Pointe-Claire, Quebec) was used in all infusions. The
gadolinium-DTPA was diluted in PBS solution to a 1 mM
concentration.
Convective Co-Infusion of Growth Factors and Gadolinium-
DTPA. Six (two controls, two treated with Dll4, and two treated
with Ang2) adult primates (Macaca mulatta) underwent convection
enhanced delivery (CED) co-infusions to the right striatum. Each
animal received 120 microliters of aCSF, Dll4 (0.4 mg/ml) or
Ang2 (0.2 mg/ml) in PBS with BSA carrier (0.1%) and
gadolinium-DTPA (1 mM). The animals were sedated,
intubated and placed under isoflurane general endotracheal
anesthesia. The animals’ temperature, heart rate, oxygen
saturation, electrocardiographic responses and end-tidal partial
pressure of carbon dioxide were continually monitored. The head
of each animal was then secured in a stereotactic frame (model 9-
YSTI, Crist Instrument Co., Hagerstown, MD). Using sterile
technique, a midline skin incision was made from the anterior to
the posterior aspect of the vertex of the skull and self-retaining
retractors were used to expose the underlying bone. A 8 mm burr
hole was placed in the calvarium over the stereotactically
determined entry point above the target area and the
underlying dura mater was incised. A 22 gauge fused silica
outer guide cannula (outer diameter 0.027 in, inner diameter 0.02
in, from Plastics One) was stereotactically placed through the
dural opening along the target trajectory to a level 1.5 cm above
the desired striatal target. The guide cannula (28 gauge, made of
fused silica) was secured to the calvarium with
methylmethacrylate. The inner cannula (outer diameter 0.014
in, inner diameter 0.006 in, from Plastics One), after being
connected to the infusion apparatus, was placed through the
outer guide cannula to the target.
To distribute infusate to the striatum using CED, we used a
noncompliant delivery system that is gastight with no dead volume
that has been described previously. A Harvard syringe pump
(PHD 2000, Harvard Apparatus, Inc., South Natick, MA) was
used to generate continuous pressure throughout the infusion
procedure. During infusion, pressure was transmitted from the
pump to a glass, gastight, infusate-filled Hamilton syringe (250
microliter total volume) that was connected to PE50 thick walled
polyethylene tubing (outer diameter 0.050 in, inner diameter
0.023 in) (Plastics One, Roanoke, VA). The tubing was connected
to the distal end of the inner infusion cannula and the tip was
placed directly into striatum. Infusions were carried out at
0.5 microliters/minute. After the infusion was complete, the
cannulas were removed and the animals were euthanized. During
the euthanizing process the brain was flushed with heparinized
saline and 4% paraformaldehyde solutions prior to being removed.
A 1.5 cm thick bilateral coronal slab was removed from the fixed
brain, which included both the ipsilateral and contralateral infused
hemispheres and was immediately snap frozen for later immuno-
histochemistry assays.
Imaging of Factors and Gadolinium-DTPA
Distribution. After placement of the infusion cannula,
coronal T1-weighted MR images were obtained to determine
the precise location of the infusion cannulas. Once cannula
placement was confirmed, infusions were started and T1-weighted
MR-images were obtained in 3 planes (sagittal, axial, and coronal;
slice thickness 1 mm, 0 mm spacing) using a 3 Tesla MRI-scanner.
Images were obtained at approximately 10 to 20 minute intervals
until the infusions were complete.
Cell numbers and vascular effects were assessed by immuno-
histochemistry using several (typically 6) coronal sections taken
between +21 mm and +31 mm relative to Ear Bar Zero (EBZ).
Reagents
We used the following reagents and antibodies: FGF2 (233-FB),
mouse Dll4 (1389-D4), fibronectin (1030-FN), human angiopoie-
tin-2 (623-AN), from R&D; JAK Inhibitor I (420099), from
Calbiochem; Polyornithine (P-3655), insulin (I9278), Cholera toxin
(C8052) from Sigma; BrdU (84447723) from Boehringer;
Fluorogold from Fluorochrome, LLC; Alexa-Fluor-conjugated
secondary antibodies, AlexaFluor conjugated Cholera Toxin
Subunit B (C22841, C22842, C22843), and Alexa-conjugated
Phalloidin (A12379) from Invitrogen; DAPI (D-8417) from Sigma,
and general chemicals from Sigma. For immunohistochemical
staining, we used antibodies against the following markers: nestin
(Chemicon, MAB353), Tuj1 (Covance, MMS-435P), GFAP
(z0334) from Dako; CNPase (Chemicon, MAB326), BrdU
(Accurate, H5903), Sox2 (R&D, MAB2018); Hes3 (25393), Tie2
(sc-324), Tie2 (sc-31266), STAT3 (482), from Santa Cruz; pTie2
(AF2720) from R&D Systems; a-tubulin, Tie2 (R&D, AF313),
pTie2 (R&D, AF2720) from (Sigma, T-6074).
3D image reconstruction
We used the Volocity 3D imaging software by Improvision
(http://www.improvision.com/products/volocity/) and Zeiss Ax-
iovision (http://www.zeiss.com) software on confocal z-stacks.
Cholera on Neural Stem Cells
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Results shown are the mean 6 s.e.m. Asterisks identify
experimental groups that were significantly different (p-value
,0.05) from control groups by the Student’s t-test (Microsoft
Excel), where applicable. The p values shown are within the value
allowed after Bonferroni correction. In figure 6e (Rotometry dose
curves), the asterisks represent statistical significance as determined
by two-way ANOVA analysis (by the GraphPad Prism software).
A supplementary table is presented with the p values for each
experiment (Table S1).
Supporting Information
Figure S1 Cholera toxin labels differentiated cells in culture.
(a,b) CholB labels differentiated DCX+ cells and fibroblast
contaminants in culture; NSCs are identified by Tie2 immuno-
reactivity. (c) Adult monkey Hes3+ striatal neural precursors are
not labeld by CholB. (d) A 30 min pulse of CholB in fetal NSC
cultures 2 days after FGF2 withdrawal labels neurons, astrocytes
and oligodendrocytes (chased for 6-days). [Size bars: 20 mm].
Found at: doi:10.1371/journal.pone.0010841.s001 (3.43 MB TIF)
Figure S2 Cholera toxin promotes the nuclear localization of
Hes3. CholAB (2-d treatment) promotes the nuclear localization of
Hes3 in the presence and absence of FGF2 in fetal NSC cultures;
split channels from confocal projections are shown [Size bars:
100 mm].
Found at: doi:10.1371/journal.pone.0010841.s002 (3.79 MB TIF)
Figure S3 Cholera toxin promotes the nuclear localization of
Hes3. High-power magnification of the images described in Suppl.
Fig. S2 [Size bars: 20 mm].
Found at: doi:10.1371/journal.pone.0010841.s003 (2.89 MB TIF)
Figure S4 Cholera toxin inhibits the differentiation of fetal
NSCs in culture. (a) Fetal NSC cultures expanded in FGF2 (4-
days) and then switched to FGF2+/2 CholAB - containing
medium do not acquire immuno-reactivity for GFAP or TUJ1. (b)
Fetal NSC cultures expanded in FGF2 (6-days) and then switched
to +/2 CholAB conditions, in the absence of FGF2 (for 2-days) do
not acquire immuno-reactivity for GFAP or TUJ1. [Size bars:
200 mm].
Found at: doi:10.1371/journal.pone.0010841.s004 (1.34 MB TIF)
Table S1 Significance (p) values.
Found at: doi:10.1371/journal.pone.0010841.s005 (0.04 MB
DOC)
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